IMV Inc. to Present at Two Upcoming Investor Conferences
Wednesday, June 19, 2019
4:10 p.m. ET
- Format: Presentation and webcast
- Location: Lotte New York Palace,
New York, NY
The Oppenheimer Summit for Emerging Biotechnology
Wednesday, June 26, 2019to Friday, June 28, 2019
- Format: Attendance and one-on-one presentations
- Location: Gurney's
Star Island Resortand Marina, Montauk, NY
A copy of each the investor presentations will be available in the events
and presentations section of IMV’s website.
Also, a live webcast of IMV’s presentation at the
IMV Forward-Looking Statements
This press release contains forward-looking information under
applicable securities law. All information that addresses activities or
developments that we expect to occur in the future is forward-looking
information. Forward-looking statements are based on the estimates and
opinions of management on the date the statements are made. In the press
release, such forward-looking statements include, but are not limited
to, statements regarding the FDA potentially granting accelerated
regulatory approval of DPX-Survivac. However, they should not be
regarded as a representation that any of the plans will be achieved.
Actual results may differ materially from those set forth in this press
release due to risks affecting the Corporation, including access to
capital, the successful design and completion of clinical trials and the
receipt and timely receipt of all regulatory approvals.
Marc Jasmin, IMV Senior Director, Investor Relations and Communications
O: (902) 492-1819 ext : 1042
M: (514) 617-9481 E: firstname.lastname@example.org
Andrea Cohen, Sam Brown Inc.
T: (917) 209-7163 E: email@example.com